EU-JAMRAI supports Member States (and other participant countries) on the implementation of some of the provisions laid down in the Council Conclusions on the next steps under a One Health approach to combat antimicrobial resistance (2016/C 269/05) unanimously adopted by the Council of the European Union in June 2016.
The Joint Action also supports Member States in the development and implementation of national strategies and national action plans on AMR in line with the tripartite (WHO, FAO, OIE) Global Action Plan (GAP) on AMR and to reinforce the collaboration between Member States, European Commission and other European and international organisations on the implementation of these strategies.
To reach this objective, the Joint Action has developed a self-assessment tool to monitor country progress and identify gaps and shortcomings on the implementation of national strategies and national action plans. EU-JAMRAI has set up a country-to-country peer review system to evaluate each other’s national action plans and reflect about policy options.This week, Spain (Spanish Agency of Medicines and Medical Devices) will share with Netherlands its experience with its National Action Plan.
Furthermore, to ensure the sustainability of results and actions initiated during the Joint Action beyond the 3-year JA duration, the JA work will report regularly and discuss within the One Health Network described in the Council Conclusions.